Journal article

DNA methylation analysis of the HIF-1α prolyl hydroxylase domain genes PHD1, PHD2, PHD3 and the factor inhibiting HIF gene FIH in invasive breast carcinomas

KT Huang, T Mikeska, A Dobrovic, SB Fox

Histopathology | WILEY | Published : 2010

Abstract

Aims: Hypoxia-inducible factor-1 (HIF-1) activity is regulated by prolyl hydroxylase (PHD1, PHD2, PHD3) and factor inhibiting HIF-1 (FIH) that target the α subunit of HIF-1 (HIF-1α) for proteosomal degradation. We hypothesised that the elevated HIF-1α level is due in some tumours to epigenetic silencing by DNA hypermethylation of the promoter region of one or more of the PHDs and FIH genes. The aims were to define the presence or absence of promoter methylation of PHDs and FIH in cell lines of various sources and breast carcinomas and, if present, determine its effect on mRNA and protein expression. Methods and results: Tumour cell lines (n = 20) and primary invasive breast carcinomas (n = 1..

View full abstract

University of Melbourne Researchers

Grants

Funding Acknowledgements

We thank Elena Takano for her advice in immunohistochemistry work. We would also like to thank Professor Adrian Harris for supplying us with the sample DNA and the Molecular Pathology Research and Development group in Peter MacCallum Cancer Centre for their help and support. This work was funded by a grant from the Victorian Breast Cancer Research Consortium of Australia to SF and a grant from the National Breast Cancer Foundation of Australia to AD.